je.st
news
Takeda, Lilly lose bid to overturn $9 billion award for hiding cancer risk
2014-08-30 03:04:00| Biotech - Topix.net
Takeda Pharmaceuticals and Eli Lilly & Co lost a bid to overthrow a combined $9 billion punitive-damage award by a U.S. jury for hiding cancer risks associated with their Actos diabetes drug, according to a court ruling.
Tags: risk
award
bid
cancer
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||